{"id":80316,"date":"2026-05-06T12:01:49","date_gmt":"2026-05-06T12:01:49","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/"},"modified":"2026-05-06T12:01:49","modified_gmt":"2026-05-06T12:01:49","slug":"abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/","title":{"rendered":"ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors"},"content":{"rendered":"<div>\n<p><em>Dr. Doody joins from Senior Leadership in Neurodegeneration at F. Hoffman-LaRoche LTD and biotech Axxium Life<\/em><\/p>\n<p align=\"justify\">ATLANTA and BOSTON, May  06, 2026  (GLOBE NEWSWIRE) &#8212; ABLi Therapeutics (\u201cABLi\u201d), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosine Kinases (c-Abl kinases), announces the appointment of world renowned industry veteran in clinical development of neurodegeneration therapeutics, Rachelle S. Doody, MD, PhD, to the ABLi Board of Directors.<\/p>\n<p align=\"justify\">Dr. Doody has over 10 years of pharmaceutical leadership experience in clinical development of therapeutics to fight neurodegenerative diseases, including Alzheimer\u2019s and Parkinson\u2019s disease. She was Global Head of Neurodegeneration in late stage Neuroscience at F. Hoffman-LaRoche (Roche) where she led the development of the monoclonal antibodies Crenezumab and Gantenerumab for familial and sporadic AD; led the late stage development for Tominersin, an antisense oligonucleotide for Huntington\u2019s Disease, and led the late-stage development program for Prasinezumab, an anti-alpha synuclein monoclonal antibody for Parkinson\u2019s disease that is now in Phase 3 development. After leaving Roche in 2024, she joined the biotechnology company Axxium Life as Chief Medical Officer and Director of Development, where she oversees a pipeline of active immunotherapy medications directed against chronic and neurodegenerative diseases.<\/p>\n<p align=\"justify\">Prior to her tenure at Roche, Dr. Doody was the Effie Marie Cain Chair in Alzheimer\u2019s Disease research at Baylor College of Medicine and is presently a Distinguished Emeritus Professor in Neurology.<\/p>\n<p align=\"justify\">Dr. Doody trained in internal medicine at McGill University, the Royal Victoria Hospital and the Montreal Neurological Hospital and Institute and did her residency in Neurology at Baylor where she honed her interests and expertise in Alzheimer\u2019s Disease. Her PhD work in cognitive anthropology was completed at Rice University.<\/p>\n<p align=\"justify\">\u201cThe appointment of Dr. Doody brings to the ABLi Board an industry leader in the development of neurodegenerative disease therapeutics,\u201d said Dr. Milton Werner, ABLi\u2019s Chairman and Chief Executive Officer. \u201cDr. Doody will advise the company on management best practices and clinical trial design as we prepare to launch our Phase 3 programs for Parkinson\u2019s, Multiple System Atrophy (MSA) and Dementia with Lewy Body (DLB).\u201d<\/p>\n<p align=\"justify\">\u201cPatients with neurodegenerative diseases need more and better treatments than what is available today. I am pleased to join the Board at ABLi to extend my assistance to another promising biotechnology company with the potential to really impact the synucleinopathies, such as Parkinson\u2019s disease, MSA and DLB.\u201d<\/p>\n<p><strong>About Risvodetinib (ABLi-148009)<\/strong><\/p>\n<p align=\"justify\">Risvodetinib is a potent, selective small-molecule inhibitor of the non-receptor c-Abl kinases, designed for once-daily oral use that targets the underlying biological mechanisms driving Parkinson\u2019s disease initiation and progression. Risvodetinib has been demonstrated to modify the PD pathophysiologic pathway and shown to impact the neurodegenerative and neuroinflammatory disease processes in humans as a once-per-day oral therapy. All marketed therapeutic approaches to treat Parkinson\u2019s disease help manage symptoms, but there are currently no available treatments to slow or stop the disease\u2019s relentless progression.\u00a0\u00a0 Recently, risvodetinib was the first monotherapy to improve patient quality of life in a randomized, placebo-controlled clinical trial (NCT NCT05424276) and simultaneously reduced the underlying disease pathology and suppressed the underlying disease process in patients with untreated Parkinson\u2019s disease. Risvodetinib currently has intellectual property protection beyond 2036.<\/p>\n<p><strong>About ABLi Therapeutics<\/strong><\/p>\n<p align=\"justify\">ABLi Therapeutics (\u201cABLi\u201d) applies innovative medicinal chemistry and a deep understanding of disease biology to develop small molecule therapeutics that target the cause of diseases that arise from activation or dysfunction of the Abelson Tyrosine Kinases (c-Abl). Leveraging its expertise in drug design, ABLi utilizes clinically validated data of kinase inhibitors to design and develop novel product candidates with enhanced penetration into the brain, greater potency and target selectivity, and improved safety to treat diseases in which Abl kinase activation or dysfunction is implicated. The Company\u2019s primary focus is on developing therapeutics for the treatment of neurodegenerative diseases like Parkinson\u2019s disease and the Parkinson\u2019s-related neurodegenerative diseases Multiple System Atrophy and Dementia with Lewy Body that are all associated with Abl kinase activation or dysfunction. For more information visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=16UrZxy08ZWsVzKofwLKm8kzuP7jUDWKcBoGYOzdd9F___4Tn9ZEr-H-KlU1vxGxJ7uVk3jzSz5fSOu31XtyrzsErxVy31cMYIdMjm6w3fU0z7XqZpjNTS8OVPK1CPfi\" rel=\"nofollow\" target=\"_blank\" title=\"www.ablitherapeutics.com\">www.ablitherapeutics.com<\/a> or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AGF339PQyD16AljfSlwwNmYdm-5MAVuIPp4YLrCxWJRJ3mI_SCrD3gazXPFi_fyfbyjOv8hZU8ot_rYJReYwdJpMoGDymOblASlYXlc-vRp1DQktiM1_ZH9EKsVT-r8J\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a> and X.<\/p>\n<p align=\"justify\"><strong>Contacts:<\/strong><\/p>\n<p align=\"justify\"><em>For ABLi Therapeutics<\/em><br \/>Milton H Werner PhD<br \/>Chairman &amp; CEO<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MU1sagWJBn24lx5sPO2PU2YqfeOjV0mVtjbB2ebT5XK7hSWmxLOjqn03Gw671zYHq0Sr1_EW4Hw7e5kOOeJQzO982QNfpAWUAKtL18eC_XvaLNGafgOjQ1Wat1vrel9u\" rel=\"nofollow\" target=\"_blank\" title=\"info@ablitherapeutics.com\">info@ablitherapeutics.com<\/a><\/p>\n<p align=\"justify\"><em>Investor\/Media<\/em><br \/>Mike Moyer<br \/>Managing Director \u2013 LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gdTBkam4_I0x5M6Wa35LqeJMABrXvO_8O1NVgsOCNLbo9HykzHP7-1OA4iUvPmSymfNtz9F83EiKksrAgyq5hx4tFpjiOzo8-ttd-KkHJAaK_M7ABvGEOKf8jsCY2Z8n\" rel=\"nofollow\" target=\"_blank\" title=\"mmoyer@lifesciadvisors.com\">mmoyer@lifesciadvisors.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmU5M2NjYzEtYzNiYi00YjFhLWFkYmUtMWZjNjgxZThmNGMwLTUwMDE0NTk4Ny0yMDI2LTA1LTA2LWVu\/tiny\/ABLi-Therapeutics.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Doody joins from Senior Leadership in Neurodegeneration at F. Hoffman-LaRoche LTD and biotech Axxium Life ATLANTA and BOSTON, May 06, 2026 (GLOBE NEWSWIRE) &#8212; ABLi Therapeutics (\u201cABLi\u201d), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosine Kinases (c-Abl kinases), announces the appointment of world renowned industry veteran in [&#8230;]\n","protected":false},"author":1,"featured_media":85254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-80316","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors\" \/>\n<meta property=\"og:description\" content=\"Dr. Doody joins from Senior Leadership in Neurodegeneration at F. Hoffman-LaRoche LTD and biotech Axxium Life ATLANTA and BOSTON, May 06, 2026 (GLOBE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-06T12:01:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/04\/sgb-media-kit-2026.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1075\" \/>\n\t<meta property=\"og:image:height\" content=\"716\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors\",\"datePublished\":\"2026-05-06T12:01:49+00:00\",\"dateModified\":\"2026-05-06T12:01:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/\"},\"wordCount\":709,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/\",\"name\":\"ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-05-06T12:01:49+00:00\",\"dateModified\":\"2026-05-06T12:01:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors","og_description":"Dr. Doody joins from Senior Leadership in Neurodegeneration at F. Hoffman-LaRoche LTD and biotech Axxium Life ATLANTA and BOSTON, May 06, 2026 (GLOBE","og_url":"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-05-06T12:01:49+00:00","og_image":[{"width":1075,"height":716,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/04\/sgb-media-kit-2026.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors","datePublished":"2026-05-06T12:01:49+00:00","dateModified":"2026-05-06T12:01:49+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/"},"wordCount":709,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/","url":"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/","name":"ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-05-06T12:01:49+00:00","dateModified":"2026-05-06T12:01:49+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/80316","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=80316"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/80316\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/85254"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=80316"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=80316"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=80316"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}